Literature DB >> 17706469

Does chronic mountain sickness (CMS) have perinatal origins?

Lorna G Moore1, Susan Niermeyer, Enrique Vargas.   

Abstract

Chronic mountain sickness (CMS) occurs in approximately 10% of male high-altitude residents. It is characterized by hypoventilation and hypoxemia but its underlying cause remains unknown. We hypothesized that CMS' origins reside in exaggerated perinatal hypoxia that serves, in turn, to impair the development of pulmonary structure and/or respiratory control. As a preliminary test, we asked if birth weights were low and other signs of perinatal hypoxia were present in 12 young men with excessive erythrocytosis (EE, Hb>or=18.3g/dL), a condition thought to be a preclinical phase of CMS. Their birth weights were uniformly low (2571+/-243g) and all but one demonstrated perinatal hypoxia as manifested either by being small for their gestational age (SGA, 8%), preterm (67%), born to a preeclamptic (PE) mother (50%), or diagnosed with neonatal hypoxia (83%). Impaired growth in utero has been shown to raise susceptibility to adult disease; these are the first data to demonstrate a possible influence of reduced fetal growth and/or exaggerated perinatal hypoxia on increasing the susceptibility to CMS. Future studies, with more detailed testing in larger samples of control as well as EE subjects, with longitudinal follow-up, are required to determine the role of perinatal hypoxia in the development of CMS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17706469     DOI: 10.1016/j.resp.2007.06.016

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  17 in total

1.  Appetite at high altitude: an fMRI study on the impact of prolonged high-altitude residence on gustatory neural processing.

Authors:  Xiaodan Yan; Jiaxing Zhang; Qiyong Gong; Xuchu Weng
Journal:  Exp Brain Res       Date:  2010-12-24       Impact factor: 1.972

Review 2.  New genetic and physiological factors for excessive erythrocytosis and Chronic Mountain Sickness.

Authors:  Francisco C Villafuerte
Journal:  J Appl Physiol (1985)       Date:  2015-08-13

Review 3.  Neonatal oxygenation, pulmonary hypertension, and evolutionary adaptation to high altitude (2013 Grover Conference series).

Authors:  Susan Niermeyer; Mario Patricio Andrade-M; Enrique Vargas; Lorna G Moore
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

Review 4.  Time Domains of the Hypoxic Ventilatory Response and Their Molecular Basis.

Authors:  Mathhew E Pamenter; Frank L Powell
Journal:  Compr Physiol       Date:  2016-06-13       Impact factor: 9.090

5.  Altered iPSC-derived neurons' sodium channel properties in subjects with Monge's disease.

Authors:  H W Zhao; X Q Gu; T Chailangkarn; G Perkins; D Callacondo; O Appenzeller; O Poulsen; D Zhou; A R Muotri; G G Haddad
Journal:  Neuroscience       Date:  2015-01-03       Impact factor: 3.590

6.  Low haemoglobin concentration in Tibetan males is associated with greater high-altitude exercise capacity.

Authors:  T S Simonson; G Wei; H E Wagner; T Wuren; G Qin; M Yan; P D Wagner; R L Ge
Journal:  J Physiol       Date:  2015-06-25       Impact factor: 5.182

Review 7.  Measuring high-altitude adaptation.

Authors:  Lorna G Moore
Journal:  J Appl Physiol (1985)       Date:  2017-08-31

8.  Structural modifications of the brain in acclimatization to high-altitude.

Authors:  Jiaxing Zhang; Xiaodan Yan; Jinfu Shi; Qiyong Gong; Xuchu Weng; Yijun Liu
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

Review 9.  Breathing at high altitude.

Authors:  Vincent Joseph; Jean-Marc Pequignot
Journal:  Cell Mol Life Sci       Date:  2009-09-10       Impact factor: 9.261

10.  Augmented uterine artery blood flow and oxygen delivery protect Andeans from altitude-associated reductions in fetal growth.

Authors:  Colleen Glyde Julian; Megan J Wilson; Miriam Lopez; Henry Yamashiro; Wilma Tellez; Armando Rodriguez; Abigail W Bigham; Mark D Shriver; Carmelo Rodriguez; Enrique Vargas; Lorna G Moore
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-02-25       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.